REG - Intuitive Invests.Gp - Investment in Yourgene Health plc

Intuitive InvestmentsAnnouncement

11/01/2023 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230111:nRSK3950Ma&default-theme=true

RNS Number : 3950M  Intuitive Investments Group plc  11 January 2023

11 January 2023

 

Intuitive Investments Group plc

 

Investment in Yourgene Health plc

 

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a
closed-end investment company focussed on the life sciences sector, has
invested £150,407 to acquire 50 million ordinary shares of Yourgene Health
plc (AIM: YGEN) ("Yourgene") at a price of 0.3 pence per share. IIG holds
51,584,920 ordinary shares of Yourgene in total.

 

Julian Baines, Chairman of IIG and Robert Naylor, CEO of IIG, have holdings of
5,000,000 ordinary shares and 33,497,789 ordinary shares in Yourgene
respectively.

For further information, please contact:

 Intuitive Investments Group plc                       www.iigplc.com (http://www.iigplc.com/)
 Julian Baines, Chairman                               Via Walbrook PR

 Robert Naylor, CEO

 SP Angel Corporate Finance LLP - Nominated Adviser    +44 (0) 20 3470 0470
 Jeff Keating / David Hignell / Kasia Brzozowska

 Turner Pope Investments (TPI) Ltd - Broker            +44 (0) 20 3657 0050
 Andrew Thacker / James Pope

 Walbrook PR Limited - Media & Investor Relations      +44 (0)20 7933 8780 or intuitive@walbrookpr.com
 Paul McManus / Sam Allen                              +44 (0) 7980 541 893 / +44 (0) 7502 558 258

 

About Intuitive Investments Group plc

Intuitive Investments Group plc is an investment company seeking to provide
investors with exposure to a portfolio concentrating on fast growing and/or
high potential Life Sciences businesses operating predominantly in the UK,
continental Europe and the US, utilising the Board's experience and in
particular that of the Chairman of the Investment Committee, David Evans, to
seek to generate capital growth over the long term for shareholders

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSFLSUFEDSELF